Tapentadol-ß-D-glucuronide,
|
T-060
|
100 ug/mL in 1:1 Acetonitrile:Water
The first Certified Spiking Solution® of the primary urinary metabolite of tapentadol. Tapentadol is the first new drug of the centrally-acting analgesic class approved in the US for pain management in more than 25 years. This new Certified Spiking Solution® is suitable for many LC/MS or GC/MS applications, including pain prescription monitoring, forensic testing, clinical toxicology, or urine drug testing.
|
|
|